| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $243.2M | +0.0% |
| Cost of Revenue | $63.8M | -7.0% |
| Gross Profit | $179.4M | +2.7% |
| R&D Expense | $34.2M | +5.3% |
| SG&A Expense | $45.7M | -0.7% |
| Operating Income | $48.4M | +8.1% |
| Pre-tax Income | $49.4M | +6.2% |
| Income Tax | -$23.5M | -122.2% |
| Net Income | $72.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.5M | -15.2% |
| Accounts Receivable | $56.0M | -0.4% |
| Inventory | $10.5M | -3.0% |
| Current Assets | $172.2M | -1.6% |
| Total Assets | $397.7M | +17.4% |
| Current Liabilities | $114.6M | +3.9% |
| Total Liabilities | $125.9M | -0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $59.5M | +6.8% |
| Capital Expenditures | $9.0M | -3.1% |
| Investing Cash Flow | -$35.6M | -282.4% |
| Financing Cash Flow | -$38.4M | -632.6% |
| Free Cash Flow | $50.5M | +8.8% |
| +27.7% |
| EPS (Basic) | $1.91 | +28.2% |
| EPS (Diluted) | $1.88 | +28.8% |
| Stockholders' Equity |
| $271.8M |
| +27.9% |